Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what ...

The data was still under wraps at that time, but has just been revealed in the ESMO congress abstract drop – a 3.2 month improvement over control, compared to 1.6 months at ASCO. Taken in ...

Positive clinical data with confirmed overall response rate (ORR) = 62.5% (95% CI, 30.4-86.5) and prospective ACR-368 OncoSignature patient ...

“ESMO 2022 had really outstanding sessions for ... those who are HRD-positive […] and those who are HRD-negative, meaning that they are homologous recombination proficient in their tumour ...

Completed Pre-Biologics License Application (BLA) meeting with the U.S. Food and Drug Administration (FDA) and remain on track to submit a BLA ...

On the outside, the process can seem a little random or opaque, but every Emoji inclusion is the result of careful examination regarding its meaning. The Unicode Consortium has seven criteria that ...

Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...

Here you will find news stories and blog posts about the research our scientists have presented at the congress over the years. ESMO Virtual Plenary 2022: Major trial shows targeted drug improves ...

Before we begin, I'd like to remind listeners that comments made during this call by management will include forward-looking ...

SEE ALSO: Women are using dating apps to discover their queer sexuality As is often the case within the LGBTQ community, WLW may mean different things to different people. To one person ...

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

and the European Society for Medical Oncology ("ESMO”) Asia Congress 2024, taking place on December 6-8, 2024 in Singapore. Long-term safety and efficacy data from a follow-on, open-label sub-study of ...